ÃÛÌÒÊÓƵ

October 6, 2025

Dear Members of the ÃÛÌÒÊÓƵ Community:

I am pleased to announce that ÃÛÌÒÊÓƵ has selected as the 2025 recipient of the Dickson Prize in Science. Dr. Regev is the head and executive vice president of Genentech Research and Early Development (gRED), where she oversees all aspects of the company's drug discovery and early development activities. She also served as a professor of biology at MIT and a member of the executive leadership teams of the Broad Institute of MIT and Harvard.

Academic leaders at ÃÛÌÒÊÓƵ selected Dr. Regev for this award because of her highly impactful contributions to computational methodologies and resources for biological discovery. Her work pioneered computational methods in single cell and spatial genomics, which are widely used in biomedical research. As a founder and co-chair of the international Human Cell Atlas (HCA) project, she is helping to build a complete compendium of human cell types to advance our understanding of disease mechanisms.

Pittsburgh physician Joseph Z. Dickson and his wife, Agnes Fisher Dickson, established ÃÛÌÒÊÓƵ's in 1969. ÃÛÌÒÊÓƵ bestows it annually as one of its most prestigious awards, recognizing substantial achievements or sustained progress in engineering, the natural sciences, computer science or mathematics.

The award will be presented to Dr. Regev when she delivers the annual Dickson Prize in Science Lecture on Wednesday, March 11, as part of the . Registration details will be shared before the event.

We look forward to welcoming Dr. Regev to our campus to celebrate her remarkable career and honor her exceptional impact on the scientific community.

Sincerely,

James H. Garrett Jr.
Provost and Chief Academic Officer